Inorganic Nanocrystals As Contrast Agents In MRI: Synthesis, Coating And Introduction Of Multifunctionality

NMR in Biomedicine

Volumn 26, Issue 7, 2013, Pages 766-780

  Cormode, David P ^a,b   Sanchez Gaytan, Brenda L ^a   Mieszawska, Aneta J ^a   Fayad, Zahi A ^a   Mulder, Willem J M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Biocompatible; Gold nanoparticles; Iron oxide; Molecular imaging; MRI; Multimodality; Nanoparticle; Quantum dots

Indexed keywords

BIOCOMPATIBLE; BIOCOMPATIBLE COATINGS; CONTROLLED PROPERTIES; GOLD NANOPARTICLES; INORGANIC NANOCRYSTALS; LIGAND SUBSTITUTION; MULTI-MODALITY; MYRIAD APPLICATIONS;

BIOCOMPATIBILITY; COATINGS; GENE TRANSFER; GOLD; IMAGING TECHNIQUES; IRON OXIDES; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; MOLECULAR IMAGING; NANOPARTICLES; SEMICONDUCTOR QUANTUM DOTS;

NANOCRYSTALS;

AMPHOPHILE; ARGINYLGLYCYLASPARTIC ACID; CONTRAST MEDIUM; GADOLINIUM; GOLD; INORGANIC NANOCRYSTAL; IRON OXIDE; MANGANESE OXIDE; NANOCRYSTAL; PHOSPHOLIPID; QUANTUM DOT; TOLUENE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; COMPUTER ASSISTED TOMOGRAPHY; INTERMETHOD COMPARISON; MAGNETIC FIELD; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY RADIATION; SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CONTRAST MEDIA; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INORGANIC CHEMICALS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES;

EID: 84879551870     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2909     Document Type: Article

References (146)

1. Wickline SA, Neubauer AM, Winter P, Caruthers S, Lanza G. Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology. Arterioscler. Thromb. Vasc. Biol. 2006; 26(3): 435-441.
2. Daniel M-C, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 2004; 104: 293-346.
3. Antonie F. Panacea Aurea-Auro Potabile. John Legatt: London; 1616.
4. Yu SB, Watson AD. Metal-based X-ray contrast media. Chem. Rev. 1999; 99(9): 2353-2377.
5. Corot C, Robert P, Idee J-M, Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 2006; 58: 1471-1504.
6. Food and Drug Administration. Available at: http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=020416&TABLE1=OB_Disc [accessed 17 December 2012].
7. de Mello Donega C. Synthesis and properties of colloidal heteronanocrystals. Chem. Soc. Rev. 2011; 40: 1512-1546.
8. Tao AR, Habas S, Yang PD. Shape control of colloidal metal nanocrystals. Small 2008; 4(3): 310-325.
9. Wang F, Liu XG. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem. Soc. Rev. 2009; 38(4): 976-989.
10. Trewyn BG, Slowing I, Giri S, Chen H-T, Lin VSY. Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc. Chem. Res. 2007; 40: 846-853.
11. Jeong U, Teng X, Wang Y, Yang H, Xia Y. Superparamagnetic colloids: controlled synthesis and niche applications. Adv. Mater. 2007; 19: 33-60.
12. Murphy CJ, Sau TK, Gole AM, Orendorff CJ, Gao J, Gou L, Hunyadi SE, Li T. Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J. Phys. Chem. B 2005; 109: 13 857-13 870.
13. Shankar SS, Rai A, Ankamwar B, Singh A, Ahmad A, Sastry M. Biological synthesis of triangular gold nanoprisms. Nat. Mater. 2004; 3: 482-488.
14. Jin R, Cao Y, Mirkin CA, Kelly KL, Schatz GC, Zheng JG. Photoinduced conversion of silver nanospheres to nanoprisms. Science 2001; 294(5548): 1901-1903.
15. Choi CL, Koski KJ, Sivasankar S, Alivisatos AP. Strain-dependent photoluminescence behavior of CdSe/CdS nanocrystals with spherical, linear, and branched topologies. Nano Lett. 2009; 9(10): 3544-3549.
16. Cormode DP, Skajaa T, Fayad ZA, Mulder WJM. Nanotechnology in medical imaging: probe design and applications. Arterioscler. Thromb. Vasc. Biol. 2009; 29: 992-1000.
17. Cherukuri P, Glazer ES, Curleya SA. Targeted hyperthermia using metal nanoparticles. Adv. Drug Deliv. Rev. 2010; 62(3): 339-345.
18. Haun JB, Castro CM, Wang R, Peterson VM, Marinelli BS, Lee H, Weissleder R. Micro-NMR for rapid molecular analysis of human tumor samples. Sci. Trans. Med. 2011; 3(71): 71ra16.
19. Rosi NL, Mirkin CA. Nanostructures in biodiagnostics. Chem. Rev. 2005; 105: 1547-1562.
20. Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 2008; 69: 1-9.
21. Gabizon A, Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 6949-6953.
22. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release, 2000; 65: 271-284.
23. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Ipe BI, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat. Biotechnol. 2007; 25(10): 1165-1170.
24. Libutti SK, Paciotti GF, Byrnes AA, Alexander HR, Gannon WE, Walker M, Seidel GD, Yuldasheva N, Tamarkin L. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res. 2010; 16(24): 6139-6149.
25. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 2004; 209: 171-176.
26. von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, Sailor MJ, Bhatia SN. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 2009; 69(9): 3892-3900.
27. Pilot study of AuroLase(tm) therapy in refractory and/or recurrent tumors of the head and neck. Available at: http://clinicaltrialsgov/ct2/show/NCT00848042 [accessed 17 December 2012]. Clinical trial identifier: NCT00848042.
28. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 2004; 49: N309-N315.
29. Durr NJ, Larson T, Smith DK, Korgel BA, Sokolov K, Ben-Yakar A. Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods. Nano Lett. 2007; 7(4): 941-945.
30. Qian X, Peng X-H, Ansari DO, Yin-Goen Q, Chen GZ, Shin DM, Yang L, Young AN, Wang MD, Nie S. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 2008; 26(1): 83-90.
31. Kim D, Park S, Lee JH, Jeong YY, Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo x-ray computed tomography imaging. J. Am. Chem. Soc. 2007; 129(24): 7661-7665.
32. Cormode DP, Roessl E, Thran A, Skajaa T, Gordon RE, Schlomka JP, Fuster V, Fisher EA, Mulder WJM, Proksa R, Fayad ZA. Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles. Radiology, 2010; 256(3): 774-782.
33. van Helden AK, Jansen JW, Vrij A. Preparation and characterization of spherical monodisperse silica dispersions in nonaqueous solvents. J. Colloid Interface Sci. 1980; 78(312): 354-368.
34. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat. Mater. 2005; 4: 435-446.
35. Mancini MC, Kairdolf BA, Smith AM, Nie S. Oxidative quenching and degradation of polymer-encapsulated quantum dots: new insights into the long-term fate and toxicity of nanocrystals in vivo. J. Am. Chem. Soc. 2008; 130(33): 10 836-10 837.
36. Fountaine TJ, Wincovitch SM, Geho DH, Garfield SH, Pittaluga S. Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots. Modern Pathol. 2006; 19: 1181-1191.
37. Gleich B, Weizenecker J. Tomographic imaging using the nonlinear response of magnetic particles. Nat. Biotechnol. 2005; 435: 1214-1217.
38. Campbell R. Battling tumors with magnetic nanotherapeutics and hyperthermia: turning up the heat. Nanomedicine, 2007; 2(5): 649-652.
39. Kim J, Lee JE, Lee SH, Yu JH, Lee JH, Park TG, Hyeon T. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery. Adv. Mater. 2008; 20: 478-483.
40. Lee J-S, Green JJ, Love KT, Sunshine J, Langer R, Anderson DG. Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery Nano. Lett. 2009; 9(6): 2402-2406.
41. Kievit FM, Veiseh O, Bhattarai N, Fang C, Gunn JW, Lee DH, Ellenbogen RG, Olson JM, Zhang M. PEI-PEG-chitosan-copolymer-coated iron oxide nanoparticles for safe gene delivery: synthesis, complexation, and transfection. Adv. Funct. Mater. 2009; 19: 2244-2251.
42. Qi LF, Gao XH. Quantum dot-amphipol nanocomplex for intracellular delivery and real-time imaging of siRNA. ACS Nano 2008; 2(7): 1403-1410.
43. Molday RS, Mackenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J. Immunol. Methods, 1982; 52: 353-367.
44. Alric C, Taleb J, Le Duc G, Mandon C, Billotey C, Le Meur-Herland A, Brochard T, Vocanson F, Janier M, Perriat P, Roux S, Tillement O. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J. Am. Chem. Soc. 2008; 130(18): 5908-5915.
45. Ravindra P. Protein-mediated synthesis of gold nanoparticles. Mater. Sci. Eng. B, Adv. Funct. Solid-State Mater. 2009; 163(2): 93-98.
46. Kim H-K, Jung H-Y, Park J-A, Huh M-I, Jung J-C, Chang Y, Kim T-J. Gold nanoparticles coated with gadolinium-DTPA-bisamide conjugate of penicillamine (Au@GdL) as a T1-weighted blood pool contrast agent. J. Mater. Chem. 2010; 20(26): 5411-5417.
47. Jun Y-w, Huh Y-M, Choi J-s, Lee J-H, Song H-T, Kim S, Yoon S, Kim K-S, Shin J-S, Suh J-S, Cheon J. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J. Am. Chem. Soc. 2005; 127: 5732-5733.
48. Mulder WJM, Strijkers GJ, van Tilborg GAF, Cormode DP, Fayad ZA, Nicolay K. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc. Chem. Res. 2009; 42(7): 904-914.
49. Jarzyna PA, Skajaa T, Gianella A, Cormode DP, Samber DD, Dickson SD, Chen W, Griffioen AW, Fayad ZA, Mulder WJM. Iron oxide core oil-in-water emulsions as a multifunctional nanoparticle platform for tumor targeting and imaging. Biomaterials, 2009; 30(36): 6947-6954.
50. Lim YT, Noh Y-W, Han JH, Cai Q-Y, Yoon K-H, Chung BH. Biocompatible polymer-nanoparticle-based bimodal imaging contrast agents for the labeling and tracking of dendritic cells. Small 2008; 4(10): 1640-1645.
51. Catana C, Procissi D, Wu Y, Judenhofer MS, Qi J, Pichler BJ, Jacobs RE, Cherry SR. Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc. Natl. Acad. Sci. U. S. A. 2008; 105(10): 3705-3710.
52. Lee JH, Huh YM, Jun Y, Seo J, Jang J, Song HT, Kim S, Cho EJ, Yoon HG, Suh JS, Cheon J. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 2007; 13(1): 95-99.
53. Bridot J-L, Faure A-C, Laurent S, Riviere C, Billotey C, Hiba B, Janier M, Josserand V, Coll J-L, Vander Elst L, Muller R, Roux S, Perriat P, Tillement O. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. J. Am. Chem. Soc. 2007; 129: 5076-5084.
54. Chou S-W, Shau Y-H, Wu P-C, Yang Y-S, Shieh D-B, Chen C-C. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J. Am. Chem. Soc. 2010; 132(38): 13 270-13 278.
55. Bennewitz MF, Lobo TL, Nkansah MK, Ulas G, Brudvig GW, Shapiro EM. Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI. ACS Nano 2011; 5(5): 3438-3446.
56. Cormode DP, Skajaa T, van Schooneveld MM, Koole R, Jarzyna P, Lobatto ME, Calcagno C, Barazza A, Gordon RE, Zanzonico P, Fisher EA, Fayad ZA, Mulder WJM. Nanocrystal core high-density lipoproteins: a multimodal molecular imaging contrast agent platform. Nano Lett. 2008; 8(11): 3715-3723.
57. Mulder WJM, Koole R, Brandwijk RJ, Storm G, Chin PTK, Strijkers GJ, Donega CD, Nicolay K, Griffioen AW. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett. 2006; 6(1): 1-6.
58. Oostendorp M, Douma K, Wagenaar A, Slenter JMGM, Hackeng TM, van Zandvoort MAMJ, Post MJ, Backes WH. Molecular magnetic resonance imaging of myocardial angiogenesis after acute myocardial infarction. Circulation, 2010; 121: 775-783.
59. Stasiuk GJ, Tamang S, Imbert D, Poillot C, Giardiello M, Tisseyre C, Barbier EL, Fries PH, de Waard M, Reiss P, Mazzanti M. Cell-permeable Ln(III) chelate-functionalized InP quantum dots as multimodal imaging agents. ACS Nano 2011; 5(10): 8193-8201.
60. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem. Soc. Rev. 2006; 35: 512-523.
61. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001; 219: 316-333.
62. Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17: 484-499.
63. Jarzyna PA, Gianella A, Skajaa T, Knudsen G, Deddens LH, Cormode DP, Fayad ZA, Mulder WJM. Multifunctional imaging nanoprobes. Wires: Nanomed. Nanobiotechnol. 2009; 2(2): 138-150.
64. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 1951; 11: 55-75.
65. Frens G. Controlled nulceation for regulation of particle size in monodisperse gold suspensions. Nat. Phys. Sci. 1973; 241(105): 20-22.
66. Pernodet N, Fang X, Sun Y, Bakhtina A, Ramakrishnan A, Sokolov J, Ulman A, Rafailovich M. Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. Small 2006; 2(6): 766-773.
67. Jana NR, Gearheart L, Murphy CJ. Wet chemical synthesis of high aspect ratio cylindrical gold nanorods. J. Phys. Chem. B 2001; 105(19): 4065-4067.
68. Nehl CL, Liao H, Hafner JH. Optical properties of star-shaped gold nanoparticles. Nano Lett. 2006; 6(4): 683-688.
69. Brust M, Walker M, Bethell D, Schiffrin DJ, Whyman R. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. Chem. Commun. 1994: 801-802.
70. Hostetler MJ, Wingate JE, Zhong CJ, Harris JE, Vachet RW, Clark MR, Londono JD, Green SJ, Stokes JJ, Wignall GD, Glish GL, Porter MD, Evans ND, Murray RW. Alkanethiolate gold cluster molecules with core diameters from 1.5 to 5.2nm: core and monolayer properties as a function of core size. Langmuir, 1998; 14: 17-30.
71. Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans. Magn. 1981; 17(2): 1247-1248.
72. Fauconnier N, Pons JN, Roger J, Bee A. Thiolation of maghemite nanoparticles by dimercaptosuccinic acid. J. Colloid Interface Sci. 1997; 194(2): 427-433.
73. Park J-A, Kim H-K, Kim J-H, Jeong S-W, Jung J-C, Lee G-H, Lee J, Chang Y, Kim T-J. Gold nanoparticles functionalized by gadolinium-DTPA conjugate of cysteine as a multimodal bioimaging agent. Bioorg. Med. Chem. Lett. 2010; 20(7): 2287-2291.
74. Kwon SG, Piao Y, Park J, Angappane S, Jo Y, Hwang N-M, Park J-G, Hyeon T. Kinetics of monodisperse iron oxide nanocrystal formation by "heating-up" process. J. Am. Chem. Soc. 2007; 129: 12 571-12 584.
75. Park J, An K, Hwang Y, Park J-G, Noh H-J, Kim J-Y, Park J-H, Hwang N-M, Hyeon T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat. Mater. 2004; 3: 891-895.
76. Pisanic TR, Blackwell JD, Shubayev VI, Finones RR, Jin S. Nanotoxicity of iron oxide nanoparticle internalization in growing neurons. Biomaterials 2007; 28(16): 2572-2581.
77. Park J-A, Reddy PAN, Kim H-K, Kim I-S, Kim G-C, Chang Y, Kim T-J. Gold nanoparticles functionalised by Gd-complex of DTPA-bis(amide) conjugate of glutathione as an MRI contrast agent. Bioorg. Med. Chem. Lett. 2008; 18(23): 6135-6137.
78. Park J, Joo J, Kwon SG, Jang Y, Hyeon T. Synthesis of monodisperse spherical nanocrystals. Angew. Chem. Int. Ed. 2007; 46: 4630-4660.
79. Murray CB, Norris DJ, Bawendi MG. Synthesis and characterization of nearly monodisperse CdE (E=S, Se, Te) semiconductor nanocrystallites. J. Am. Chem. Soc. 1993; 115(19): 8706-8715.
80. You CC, Miranda OR, Gider B, Ghosh PS, Kim IB, Erdogan B, Krovi SA, Bunz UHF, Rotello VM. Detection and identification of proteins using nanoparticle-fluorescent polymer 'chemical nose' sensors. Nat. Nanotechnol. 2007; 2(5): 318-323.
81. Yildiz I, Deniz E, McCaughan B, Cruickshank SF, Callan JF, Raymo FM. Hydrophilic CdSe-ZnS core-shell quantum dots with reactive functional groups on their surface. Langmuir 2010; 26(13): 11 503-11 511.
82. Chan WCW, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 1998; 281(5385): 2016-2018.
83. Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A. In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002; 298: 1759-1762.
84. Kim BS, Qiu JM, Wang JP, Taton TA. Magnetomicelles: composite nanostructures from magnetic nanoparticles and cross-linked amphiphilic block copolymers. Nano Lett. 2005; 5(10): 1987-1991.
85. Available at: http://www.sigmaaldrich.com/materials-science/nanomaterials.html 85-88 [accessed 17 December 2012].
86. Available at: http://www.nanopartz.com/ [accessed 17 December 2012].
87. Available at: http://www.oceannanotech.com/ [accessed 17 December 2012].
88. Available at: http://www.nn-labs.com/ [accessed XX XXXX XXXX].
89. Song Y, Xu X, MacRenaris KW, Zhang X-Q, Mirkin CA, Meade TJ. Multimodal gadolinium-enriched DNA-gold nanoparticle conjugates for cellular imaging. Angew. Chem. 2009; 121: 9307-9311.
90. Debouttière P-J, Roux S, Vocanson F, Billotey C, Beuf O, Favre-Règuillon A, Lin Y, Pellet-Rostaing S, Lamartine R, Perriat P, Tillement O. Design of gold nanoparticles for magnetic resonance imaging. Adv. Funct. Mater. 2006; 16: 2330-2339.
91. Lim YT, Cho MY, Choi BS, Lee JM, Chung BH. Paramagnetic gold nanostructures for dual modal bioimaging and phototherapy of cancer cells. Chem. Commun. 2008: 4930-4932.
92. Marradi M, Alcantara D, de la Fuente JM, Garcia-Martin ML, Cerdan S, Penades S. Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: tuning relaxivities with sugars. Chem. Commun. 2009; 3922-3924.
93. Moriggi L, Cannizzo C, Dumas E, Mayer CR, Ulianov A, Helm L. Gold nanoparticles functionalized with gadolinium chelates as high-relaxivity MRI contrast agents. J. Am. Chem. Soc. 2009; 131(31): 10 828-10 829.
94. Oostendorp M, Douma K, Hackeng TM, Dirksen A, Post MJ, van Zandvoort MAMJ, Backes WH. Quantitative molecular magnetic resonance imaging of tumor angiogenesis using cNGR-labeled paramagnetic quantum dots. Cancer Res. 2008; 68(18): 7676-7683.
95. Oostendorp M, Douma K, Hackeng TM, van Zandvoort MAMJ, Post MJ, Backes WH. Pharmacokinetics of contrast agents targeted to the tumor vasculature in molecular magnetic resonance imaging. Contrast Media Mol. Imaging 2010; 5(1): 9-17.
96. Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media. Invest. Radiol. 2008; 43(1): 65-75.
97. Lutz J-F, Stiller S, Hoth A, Kaufner L, Pison U, Cartier R. One-pot synthesis of PEGylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents. Biomacromolecules 2006; 7: 3132-3138.
98. Ma Z, Guan Y, Liu H. Synthesis and characterization of micron-sized monodisperse superparamagnetic polymer particles with amino groups. J. Polym. Sci. A: Polym. Chem. 2005; 43(15): 3433-3439.
99. 4 particles by precipitation in the presence of PVA at high pH. J. Colloid Interface Sci. 1996; 177: 490-494.
100. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001; 103: 415-422.
101. Wunderbaldinger P, Josephson L, Weissleder R. Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad. Radiol. 2002; 9(Suppl 2): S304-S306.
102. Nahrendorf M, Zhang H, Hembrador S, Panizzi P, Sosnovik DE, Aikawa E, Libby P, Swirski FK, Weissleder R. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008; 117: 379-387.
103. Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P, Weissleder R. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006; 114: 1504-1511.
104. Funovics M, Montet X, Reynolds F, Weissleder R, Josephson L. Nanoparticles for the optical imaging of tumor E-selectin. Neoplasia 2005; 7(10): 904-911.
105. Schellenberger EA, Sosnovik D, Weissleder R, Josephson L. Magneto/optical annexin V, a multimodal protein. Bioconjug. Chem. 2004; 15(5): 1062-1067.
106. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. 2005; 96: 327-336.
107. 64Cu-doped iron oxide nanoparticles. ACS Nano 2012; 6(4): 3461-3467.
108. 99mTc-bisphosphonate-iron oxide nanoparticle conjugates for dual-modality biomedical imaging. Bioconjug. Chem. 2011; 22: 455-465.
109. Lu A-H, Salabas EL, Schuth F. Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 2007; 46: 1222-1244.
110. 3 nanoparticles. Chem. Mater. 2002; 14(6): 2628-2636.
111. Xu C, Xu K, Gu H, Zheng R, Liu H, Zhang X, Guo Z, Xu B. Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. J. Am. Chem. Soc. 2004; 126(32): 9938-9939.
112. 4 dendron-nanocrystals dispersible in both organic and aqueous solutions. Adv. Mater. 2005; 17(11): 1429-1432.
113. Kim S-W, Kim S, Tracy JB, Jasanoff A, Bawendi MG. Phosphine oxide polymer for water-soluble nanoparticles. J. Am. Chem. Soc. 2005; 127(13): 4556-4557.
114. De Palma R, Peeters S, Van Bael MJ, Van den Rul H, Bonroy K, Laureyn W, Mullens J, Borghs G, Maes G. Silane ligand exchange to make hydrophobic superparamagnetic nanoparticles water-dispersible. Chem. Mater. 2007; 19: 1821-1831.
115. Zhang L, Xue H, Gao C, Carr L, Wang J, Chu B, Jiang S. Imaging and cell targeting characteristics of magnetic nanoparticles modified by a functionalizable zwitterionic polymer with adhesive 3, 4-dihydroxyphenyl-l-alanine linkages. Biomaterials 2010; 31(25): 6582-6588.
116. Lartigue L, Innocenti C, Kalaivani T, Awwad A, Sanchez Duque MdM, Guari Y, Larionova J, Guerin C, Montero J-LG, Barragan-Montero V, Arosio P, Lascialfari A, Gatteschi D, Sangregorio C. Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties. J. Am. Chem. Soc. 2011; 133(27): 10459-10472.
117. Patel D, Kell A, Simard B, Xiang B, Lin HY, Tian G. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents. Biomaterials 2011; 32(4): 1167-1176.
118. Huang C, Neoh KG, Kang E-T. Combined ATRP and 'click' chemistry for designing stable tumor-targeting superparamagnetic iron oxide nanoparticles. Langmuir 2011; 28(1): 563-571.
119. Liu D, Wu W, Ling J, Wen S, Gu N, Zhang X. Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging. Adv. Funct. Mater. 2011; 21: 1498-1504.
120. Amstad E, Zurcher S, Mashaghi A, Wong JY, Textor M, Reimhult E. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging. Small, 2009; 5(11): 1334-1342.
121. Reinicke S, Dohler S, Tea S, Krekhova M, Messing R, Schmidt AM, Schmalz H. Magneto-responsive hydrogels based on maghemite/triblock terpolymer hybrid micelles. Soft Matter 2010; 6: 2760-2773.
122. Mulder WJM, Castermans K, van Beijnum JR, oude Egbrink MGA, Chin PTK, Fayad ZA, Lowik CWGM, Kaijzel EL, Que I, Storm G, Strijkers GJ, Griffioen AW, Nicolay K. Molecular imaging of tumor angiogenesis using alpha-v-beta-3-integrin targeted multimodal quantum dots. Angiogenesis 2009; 12: 17-24.
123. van Tilborg GAF, Mulder WJM, Deckers N, Storm G, Reutelingsperger CPM, Strijkers GJ, Nicolay K. Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug. Chem. 2006; 17(3): 741-749.
124. Nitin N, LaConte LEW, Zurkiya O, Hu X, Bao G. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent. J. Biol. Inorg. Chem. 2004; 9(6): 706-712.
125. Koole R, van Schooneveld MM, Hilhorst J, Mulder WJM, Cormode DP, Strijkers GJ, Castermans K, De Mello Donega C, Vanmaekelbergh D, Griffioen A, Nicolay K, Fayad ZA, Meijerink A. Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjugate Chem. 2008; 19(12): 2471-2479.
126. van Schooneveld MM, Vucic E, Koole R, Zhou Y, Stocks J, Cormode DP, Tang CY, Gordon R, Nicolay K, Meijerink A, Fayad ZA, Mulder WJM. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett. 2008; 8(8): 2517-2525.
127. van Schooneveld MM, Cormode DP, Koole R, van Wijngaarden JT, Calcagno C, Skajaa T, Hilhorst J, Hart DC, Fayad ZA, Mulder WJM, Meijerink A. A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, and fluorescence imaging. CT Contrast Media Mol. Imaging 2010; 5(4): 231-236.
128. Talelli M, Rijcken CJF, Lammers T, Seevinck PR, Storm G, van Nostrum CF, Hennink WE. Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. Langmuir 2009; 25(4): 2060-2067.
129. Lu J, Ma S, Sun J, Xia C, Liu C, Wang Z, Zhao X, Gao F, Gong Q, Song B, Shuai X, Ai H, Gu Z. Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging. Biomaterials 2009; 30(15): 2919-2928.
130. Nasongkla N, Bey E, Ren J, Ai H, Khemtong C, Guthi JS, Chin S-F, Sherry AD, Boothman DA, Gao J. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 2006; 6(11): 2427-2430.
131. Khemtong C, Kessinger CW, Ren J, Bey EA, Yang S-G, Guthi JS, Boothman DA, Sherry AD, Gao J. In vivo off-resonance saturation magnetic resonance imaging of alpha-v-beta-3-targeted superparamagnetic nanoparticles. Cancer Res. 2009; 69(4): 1651-1658.
132. Hu J, Qian Y, Wang X, Liu T, Liu S. Drug-loaded and superparamagnetic iron oxide nanoparticle surface-embedded amphiphilic block copolymer micelles for integrated chemotherapeutic drug delivery and MR imaging. Langmuir 2011; 28(4): 2073-2082.
133. McMahon KM, Mutharasan RK, Tripathy S, Veliceasa D, Bobeica M, Shumaker DK, Luthi AJ, Helfand BT, Ardehali H, Mirkin CA, Volpert O, Thaxton CS. Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. Nano Lett. 2011; 11(3): 1208-1214.
134. Bruns OT, Ittrich H, Peldschus K, Kaul MG, Tromsdorf UI, Lauterwasser J, Nikolic MS, Mollwitz B, Merkel M, Bigall NC, Sapra S, Reimer R, Hohenberg H, Weller H, Eychmuller A, Adam G, Beisiegel U, Heeren J. Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. Nat. Nano 2009; 4(3): 193-201.
135. Skajaa T, Cormode DP, Falk E, Mulder WJM, Fisher EA, Fayad ZA. High density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2010; 30(2): 169-176.
136. Skajaa T, Cormode DP, Jarzyna PA, Delshad A, Blachford C, Barazza A, Fisher EA, Gordon RE, Fayad ZA, Mulder WJM. The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis. Biomaterials 2011; 32: 206-213.
137. Gianella A, Jarzyna PA, Mani V, Ramachandran S, Calcagno C, Tang J, Kann B, Dijk WJR, Thijssen VL, Griffioen AW, Storm G, Fayad ZA, Mulder WJM. Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. ACS Nano 2011; 5(6): 4422-4433.
138. van Tilborg GAF, Cormode DP, Jarzyna PA, van der Toorn A, van der Pol SMA, van Bloois L, Fayad ZA, Storm G, Mulder WJM, de Vries HE, Dijkhuizen RM. Nanoclusters of iron oxide: effect of core composition on structure, biocompatibility and cell labeling efficacy. Bioconjug. Chem. 2012; 23(5): 941-950.
139. Jin YH, Li AZ, Hazelton SG, Liang S, John CL, Selid PD, Pierce DT, Zhao JX. Amorphous silica nanohybrids: synthesis, properties and applications. Coord. Chem. Rev. 2009; 253(23-24): 2998-3014.
140. Lu C-W, Hung Y, Hsiao J-K, Yao M, Chung T-H, Lin Y-S, Wu S-H, Hsu S-C, Liu H-M, Mou C-Y, Yang C-S, Huang D-M, Chen Y-C. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett. 2007; 7(1): 149-154.
141. 2 core shell nanoparticles: when the coating matters. J. Phys. Chem. C 2011; 116(3): 2285-2291.
142. Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008; 2(5): 889-896.
143. Kim J, Lee JE, Lee J, Yu JH, Kim BC, An K, Hwang Y, Shin C-H, Park J-G, Kim J, Hyeon T. Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J. Am. Chem. Soc. 2006; 128(3): 688-689.
144. Duncan R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2003; 2(5): 347-360.
145. Gref R, Minamitake Y, Perachia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanosphere. Science 1994; 263: 1600-1603.
146. Nkansah MK, Thakral D, Shapiro EM. Magnetic poly(lactide-co-glycolide) and cellulose particles for MRI-based cell tracking. Magn. Reson. Med. 2011; 65(6): 1776-1785.